People · Operator
Named in public records as an officer, director or promoter · active 2015–2018 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| CytoBioscience, Inc. | — | Biotechnology | Series B | $17.4M | $60.7M | 2015 |
James R. Garvin at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside James R. Garvin on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Ian R. Clements | 1 | 1 |
| Alan R. Dean | 1 | 1 |
| Paul R. Castella | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.